On February 20, 2023, Ensol Biosciences Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,850 KRW | -1.02% | +0.10% | -22.03% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
33,750 KRW | +0.75% | +2.90% | 253M | ||
4,850 KRW | -1.02% | +0.10% | 30.2M | ||
1st Jan change | Capi. | |
---|---|---|
-22.03% | 30.2M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-10.12% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- A140610 Stock
- News Ensol Biosciences Inc.
- Ensol Biosciences Inc. announced that it has received KRW 4.99999995 billion in funding from Humedix Co., Ltd.